Flynn James E 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:17 pm Sale |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
Flynn James E | 1,125,083 2.590% |
-1,035,917 (-47.94%) |
Filing |
| 2021-02-12 12:29 pm Sale |
2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
Flynn James E | 2,161,000 5.010% |
-208,166 (-8.79%) |
Filing |
| 2020-10-26 5:08 pm Purchase |
2020-10-16 | 13G | Meridian Bioscience, Inc. VIVO |
Flynn James E | 2,369,166 5.530% |
2,369,166 (New Position) |
Filing |